{Reference Type}: Journal Article
{Title}: Magnetic resonance imaging-guided radiofrequency ablation of breast cancer: a current state of the art review.
{Author}: Zhang C;Shi J;Li B;Yu X;Feng X;Yang H;
{Journal}: Diagn Interv Radiol
{Volume}: 30
{Issue}: 1
{Year}: 01 2024 8
暂无{DOI}: 10.4274/dir.2022.221429
{Abstract}: With a gradual increase in breast cancer incidence and mortality rates and an urgent need to improve patient prognosis and cosmetology, magnetic resonance imaging (MRI)-guided radiofrequency ablation (RFA) therapy has attracted wide attention as a new treatment method for breast cancer. MRI-RFA results in a higher complete ablation rate and extremely low recurrence and complication rates. Thus, it may be used as an independent treatment for breast cancer or adjuvant to breast-conserving surgery to reduce the extent of breast resection. Furthermore, with MRI guidance, accurate control of RFA can be achieved, and breast cancer treatment can enter a new stage of minimally invasive, safe, and comprehensive therapy. With progress in MR thermometry technology, the applications of MRI are expected to broaden.